24/7 Patient Assistance: 760-405-8205

Sadakatsu Ikeda, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

Hospitals & Clinics

  • Bio & Insurance Information

    Dr. Sadakatsu Ikeda graduated from the Hokkaido University Faculty of Medicine and completed his residency program at the Mount Sinai Beth Israel. Then, he did a fellowship at the University of Michigan Hospitals and Health Centers. She is specialized in Medical Oncology and board certified in Internal Medicine, Hematology and Oncology. Dr. Ikeda has been in practice for more than 11 years and is affiliated with the UC San Diego Health System. During his career, he has also contributed to 6 clinical research publications.



  • Education & Training

    dept_icon

    Hokkaido University Faculty of Medicine

    Medical School

    dept_icon

    Mount Sinai Beth Israel

    Residency

    dept_icon

    University of Michigan Hospitals and Health Centers

    Fellowship

  • Board Certifications

    American Board of Internal Medicine

    American Board of Internal Medicine - Hematology

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    UC San Diego Health System

    Languages: English/Spanish

    (858) 657-7000

    200 West Arbor Drive

    San Diego, California 92103

    Read More
  • Publications & Memberships

    Dr. Sadakatsu Ikeda has contributed to 3 publications.

    Expression and function of microRNAs in heart disease.

    Ikeda S Pu WT; Curr Drug Targets. 2010 Aug .

    See more >>

    Transcription factor GATA4 is activated but not required for insulin-like growth factor 1 (IGF1)-induced cardiac hypertrophy.

    Bisping E, Ikeda S, Sedej M, Wakula P, McMullen JR, Tarnavski O, Sedej S, Izumo S, Pu WT, Pieske B; J. Biol. Chem.. 2012-03-23.

    See more >>

    Endostatin lowers blood pressure via nitric oxide and prevents hypertension associated with VEGF inhibition.

    Sunshine SB, Dallabrida SM, Durand E, Ismail NS, Bazinet L, Birsner AE, Sohn R, Ikeda S, Pu WT, Kulke MH, Javaherian K, Zurakowski D, Folkman JM, Rupnick M; Proc. Natl. Acad. Sci. U.S.A.. 2012-07-10.

    See more >>

    Memberships

    American Association for Cancer Research

    American Society of Clinical Oncology

    American Society of Hematology